Interventions for hospitalized medical and surgical patients with opioid use disorder: A systematic review

References

• Weiss AJ, Elixhauser A, Barrett ML, et al. Opioid-related inpatient stays and emergency department visits by state, 2009–2014: statistical brief# 219. 2017.
   Google Scholar
• Holt SR, Ramos J, Harma MA, et al. Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education. Am J Addict. 2012;21(2):111–119.
   PubMed Web of Science ®Google Scholar
• McNeely J, Gourevitch MN, Paone D, et al. Estimating the prevalence of illicit opioid use in New York City using multiple data sources. BMC Public Health. 2012;12(1):443.
   PubMedGoogle Scholar
• Blanchard J, Weiss AJ, Barrett ML, et al. Readmissions following inpatient treatment for opioid-related conditions. Subst Use Misuse. 2019;54(3):473–481.
   PubMed Web of Science ®Google Scholar
• Dewan KC, Dewan KS, Idrees JJ, et al. Trends and outcomes of cardiovascular surgery in patients with opioid use disorders. JAMA Surg. 2019;154(3):232–240.
   PubMed Web of Science ®Google Scholar
• Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145.
   PubMed Web of Science ®Google Scholar
• Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study. Subst Abus. 2020;41(4):519–525.
   PubMed Web of Science ®Google Scholar
• Strang J, Volkow ND, Degenhardt L, et al. Opioid use disorder. Nat Rev Dis Primers. 2020;6(1):1–28.
   PubMed Web of Science ®Google Scholar
• Volkow ND. Medications for opioid use disorder: bridging the gap in care. The Lancet. 2018;391(10118):285–287.
   PubMed Web of Science ®Google Scholar
• Allen B, Nolan ML, Paone D. Underutilization of medications to treat opioid use disorder: what role does stigma play? Subst Abus. 2019;40(4):459–465.
   PubMed Web of Science ®Google Scholar
• Madras BK, Ahmad NJ, Wen J, Sharfstein J. Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system. NAM Perspectives. 2020. https://doi.org/10.31478/202004b
   PubMedGoogle Scholar
• Goedel WC, Shapiro A, Cerdá M, et al. Association of racial/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States. JAMA Netw Open. 2020;3(4):e203711.
   PubMed Web of Science ®Google Scholar
• Bhatraju EP, Ludwig-Barron N, Takagi-Stewart J, et al. Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma. Drug Alcohol Depend. 2020;215:108253.
   PubMed Web of Science ®Google Scholar
• Priest KC, McCarty D. The role of the hospital in the 21st century opioid overdose epidemic: the Addiction Medicine Consult Service. J Addict Med. 2019;13(2):104–112.
   PubMed Web of Science ®Google Scholar
• Marks LR, Munigala S, Warren DK, et al. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68(11):1935–1937.
   PubMed Web of Science ®Google Scholar
• Tang VM, Lam-Shang-Leen J, Brothers TD, et al. Case series: limited opioid withdrawal with use of transdermal buprenorphine to bridge to sublingual buprenorphine in hospitalized patients. Am J Addict. 2020;29(1):73–76.
   PubMed Web of Science ®Google Scholar
• Englander H, Dobbertin K, Lind BK, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796–2803.
   PubMed Web of Science ®Google Scholar
• Nordeck CD, Welsh C, Schwartz RP, et al. Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service. Drug Alcohol Depend. 2018;186:23–28.
   PubMed Web of Science ®Google Scholar
• Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services – Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–916.
   PubMed Web of Science ®Google Scholar
• Weinstein ZM, Cheng DM, D’Amico MJ, et al. Inpatient addiction consultation and post-discharge 30-day acute care utilization. Drug Alcohol Depend. 2020;213:108081.
   PubMed Web of Science ®Google Scholar
• Suzuki J, DeVido J, Kalra I, et al. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: a case series. Am J Addict. 2015;24(1):10–14.
   PubMed Web of Science ®Google Scholar
• Patel RS, Manikkara G, Patel P, Talukdar J, Mansuri Z. Importance of behavioral therapy in patients hospitalized for post-traumatic stress disorder (PTSD) with opioid use disorder. Behav Sci. 2018;8(8):73.
   Google Scholar
• Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid agonist therapy during hospitalization within the veterans health administration: a pragmatic retrospective cohort analysis. J Gen Intern Med. 2020;35(8):2365–2374.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Wade E, Towle J, et al. Effect of inpatient medication-assisted therapy on against-medical-advice discharge and readmission rates. Am J Med. 2020;133(11):1343–1349.
   PubMed Web of Science ®Google Scholar
• Ray V, Waite MR, Spexarth FC, et al. Addiction management in hospitalized patients with intravenous drug use-associated infective endocarditis. Psychosomatics. 2020;61(6):678–687.
   PubMed Web of Science ®Google Scholar
• Thompson HM, Hill K, Jadhav R, et al. The substance use intervention team: a preliminary analysis of a population-level strategy to address the opioid crisis at an academic health center. J Addict Med. 2019;13(6):460–463.
   PubMed Web of Science ®Google Scholar
• Substance Abuse Mental Health Services Administration. Federal guidelines for opioid treatment programs. Rockville (MD): SAMHSA; 2015.
   Google Scholar
• Apodaca TR, Miller WR. A meta-analysis of the effectiveness of bibliotherapy for alcohol problems. J Clin Psychol. 2003;59(3):289–304.
   PubMed Web of Science ®Google Scholar
• Vaughn MG, Howard MO. Adolescent substance abuse treatment: a synthesis of controlled evaluations. Res Social Work Pract. 2004;14(5):325–335.
   Web of Science ®Google Scholar
• Li W, Howard MO, Garland EL, McGovern P, Lazar M. Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J Subst Abuse Treat. 2017;75:62–96.
   PubMed Web of Science ®Google Scholar
• Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S. Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series. J Addict Med. 2021;15(2):163–166.
   PubMed Web of Science ®Google Scholar
• Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016;25(3):191–194.
   PubMed Web of Science ®Google Scholar
• Cushman PA, Liebschutz JM, Anderson BJ, Moreau MR, Stein MD. Buprenorphine initiation and linkage to outpatient buprenorphine do not reduce frequency of injection opiate use following hospitalization. J Subst Abuse Treat. 2016;68:68–73.
   PubMed Web of Science ®Google Scholar
• Meyerson BE, Russell DM, Kichler M, et al. I don't even want to go to the doctor when I get sick now: healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy. 2021;93:103112.
   PubMed Web of Science ®Google Scholar
• Theisen-Toupal J, Ronan MV, Moore A, Rosenthal ES. Inpatient management of opioid use disorder: a review for hospitalists. J Hosp Med. 2017;12(5):369–374.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Robinson D, Mosquera M, et al. Impact of medications for opioid use disorder on discharge against medical advice among people who inject drugs hospitalized for infective endocarditis. Am J Addict. 2020;29(2):155–159.
   PubMed Web of Science ®Google Scholar
• Hospira. Important drug information. Hospira Web site. https://www.fda.gov/media/115316/download. Published August 2018. Accessed June 7, 2021.
   Google Scholar
• Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbid Mortal Weekly Rep. 2019;67(51–52):1419.
   Web of Science ®Google Scholar
• Kilaru AS, Xiong A, Lowenstein M, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852.
   PubMed Web of Science ®Google Scholar
• Krawczyk N, Feder KA, Fingerhood MI, Saloner B. Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a US national sample. Drug Alcohol Depend. 2017;178:512–518.
   PubMed Web of Science ®Google Scholar